At long last, the FDA approved biotech salmon, AquaAdvantage, which is bred to grow to twice the size of other fish. But in contrast to every scientific study and advisory, the editorial board of The New York Times writes that the genetically-modified fish should be labelled. We take issue with that position. Continue reading
The post Fishy Editorial on GM Salmon by the NY Times appeared first on American Council on Science and Health.
